Victory Capital Management Inc. grew its position in shares of Balchem Co. (NASDAQ:BCPC – Free Report) by 129.7% during the 3rd quarter, Holdings Channel reports. The firm owned 98,853 shares of the basic materials company’s stock after purchasing an additional 55,822 shares during the period. Victory Capital Management Inc.’s holdings in Balchem were worth $17,398,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of BCPC. Janney Montgomery Scott LLC increased its position in shares of Balchem by 53.5% during the 1st quarter. Janney Montgomery Scott LLC now owns 2,977 shares of the basic materials company’s stock valued at $461,000 after purchasing an additional 1,038 shares during the period. State Board of Administration of Florida Retirement System boosted its stake in shares of Balchem by 11.1% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 10,162 shares of the basic materials company’s stock worth $1,575,000 after acquiring an additional 1,017 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Balchem by 3.8% during the 1st quarter. Vanguard Group Inc. now owns 3,935,935 shares of the basic materials company’s stock worth $609,873,000 after acquiring an additional 144,423 shares in the last quarter. O Shaughnessy Asset Management LLC bought a new stake in shares of Balchem during the 1st quarter worth $321,000. Finally, UniSuper Management Pty Ltd bought a new stake in shares of Balchem during the 1st quarter worth $1,049,000. 87.91% of the stock is currently owned by institutional investors and hedge funds.
Balchem Stock Performance
Shares of Balchem stock opened at $177.53 on Wednesday. The stock has a market cap of $5.77 billion, a PE ratio of 47.72, a price-to-earnings-growth ratio of 5.31 and a beta of 0.65. The business has a fifty day simple moving average of $173.11 and a 200-day simple moving average of $166.15. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. Balchem Co. has a 12 month low of $120.76 and a 12 month high of $186.03.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on BCPC
About Balchem
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Featured Stories
- Five stocks we like better than Balchem
- Investing in Commodities: What Are They? How to Invest in Them
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- 3 Warren Buffett Stocks to Buy Now
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Hot Stock Trends to Ride Into 2025
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.